Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
15:21:21 EDT Wed 08 May 2024
Enter Symbol
or Name
USA
CA



News for U:PVCT from 2023-05-09 to 2024-05-08 - 18 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-05-02 08:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Announces Notice of Allowance for U.S. Patent of Oral Administration of Rose Bengal Sodium in Hematology (Leukemia)
2024-04-18 08:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Announces Publication of Preclinical Data of Oral Administration of Provectus Rose Bengal for Solid Tumor Cancers
2024-04-16 08:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder Value Creation
2024-04-11 08:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Announces Presentation of Cancer Immunotherapy PV-10 Poster for HNSCC at AACR 2024 Annual Meeting
2024-03-27 08:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Announces Exclusive Worldwide License Agreement with University of Miami for Photodynamic Antimicrobial Treatment of Different Eye Infections with Rose Bengal Sodium
2024-03-12 08:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Announces Notices of Allowance and Award for U.S. Patents of Rose Bengal Sodium in Virology, Pediatric Solid Tumor Cancers, and Vaccines
2024-03-07 08:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Announces Acceptance of Cancer Immunotherapy PV-10 Abstract for HNSCC at AACR 2024 Annual Meeting
2024-02-29 08:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Announces Acceptance of Pharmaceutical-Grade Rose Bengal Sodium Abstract for Poster Presentation at 2024 Society for Investigative Dermatology (SID) Annual Meeting
2024-02-15 08:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Announces First Quarter 2024 Conference Call
2024-02-14 08:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Engages irlabs for Investor Relations Services
2023-12-18 08:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Announces Notice of Allowance of First U.S. Patent of Rose Bengal Sodium for Use as Anticancer and Antiviral Vaccine Adjuvant
2023-11-15 09:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Advanced Cutaneous Melanoma
2023-11-13 08:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Metastatic Uveal Melanoma
2023-11-06 08:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Announces Presentation of Preclinical PV-10 Vaccine Adjuvant Data at Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
2023-08-07 07:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Announces Acceptance of PV-10 Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
2023-08-01 07:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Announces Acceptance of PV-10 Poster Presentations at Society for Melanoma Research (SMR) 2023 Congress
2023-06-28 07:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Establishes Research Collaboration with University of Tennessee College of Veterinary Medicine to Investigate Pharmaceutical-Grade Small Molecule Immunotherapy Rose Bengal Sodium for Canine Soft Tissue Sarcomas
2023-06-26 07:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Announces Stockholder Approval to Undertake Reverse Split of Outstanding Equities and Reduce Number of Authorized Equities by Same Ratio